| Faecal microbiome in new-onset juvenile idiopathic arthritis MV Tejesvi, M Arvonen, SM Kangas, PL Keskitalo, AM Pirttilä, ... European Journal of Clinical Microbiology & Infectious Diseases 35 (3), 363-370, 2016 | 105 | 2016 |
| Myelination in mouse dorsal root ganglion/Schwann cell cocultures S Päiväläinen, M Nissinen, H Honkanen, O Lahti, SM Kangas, J Peltonen, ... Molecular and Cellular Neuroscience 37 (3), 568-578, 2008 | 105 | 2008 |
| Isolation, purification and expansion of myelination‐competent, neonatal mouse Schwann cells H Honkanen, O Lahti, M Nissinen, RM Myllylä, S Kangas, S Päiväläinen, ... European Journal of Neuroscience 26 (4), 953-964, 2007 | 59 | 2007 |
| Structural analysis of the complex between calmodulin and full-length myelin basic protein, an intrinsically disordered molecule V Majava, C Wang, M Myllykoski, SM Kangas, SU Kang, N Hayashi, ... Amino Acids 39, 59-71, 2010 | 49 | 2010 |
| An investigation of herpes simplex virus type 1 latency in a novel mouse dorsal root ganglion model suggests a role for ICP34. 5 in reactivation RK Mattila, K Harila, SM Kangas, H Paavilainen, AM Heape, IJ Mohr, ... Journal of General Virology 96 (8), 2304-2313, 2015 | 28 | 2015 |
| The N‐terminal domain of the myelin enzyme 2′, 3′‐cyclic nucleotide 3′‐phosphodiesterase: direct molecular interaction with the calcium sensor calmodulin M Myllykoski, K Itoh, SM Kangas, AM Heape, SU Kang, G Lubec, I Kursula, ... Journal of neurochemistry 123 (4), 515-524, 2012 | 26 | 2012 |
| Novel variants and phenotypes widen the phenotypic spectrum of GABRG2-related disorders J Komulainen-Ebrahim, JM Schreiber, SM Kangas, K Pylkäs, ... Seizure 69, 99-104, 2019 | 22 | 2019 |
| An approach to comprehensive genome and proteome expression analyses in Schwann cells and neurons during peripheral nerve myelin formation SM Kangas, S Ohlmeier, R Sormunen, EM Jouhilahti, S Peltonen, ... Journal of Neurochemistry 138 (6), 830-844, 2016 | 10 | 2016 |
| Variant in NHLRC2 leads to increased hnRNP C2 in developing neurons and the hippocampus of a mouse model of FINCA disease AE Hiltunen, SM Kangas, S Ohlmeier, I Pietilä, J Hiltunen, H Tanila, ... Molecular Medicine 26, 1-16, 2020 | 9 | 2020 |
| Analysis of human brain tissue derived from DBS surgery SM Kangas, J Teppo, MJ Lahtinen, A Suoranta, B Ghimire, P Mattila, ... Translational neurodegeneration 11 (1), 22, 2022 | 8 | 2022 |
| Epidemiological, clinical, and genetic characteristics of paediatric genetic white matter disorders in Northern Finland OA Knuutinen, JH Oikarainen, MH Suo‐Palosaari, SM Kangas, ... Developmental Medicine & Child Neurology 63 (9), 1066-1074, 2021 | 7 | 2021 |
| Modeling rare human disorders in mice: the Finnish disease heritage T Zárybnický, A Heikkinen, SM Kangas, M Karikoski, GA Martínez-Nieto, ... Cells 10 (11), 3158, 2021 | 6 | 2021 |
| Myeloid-related protein 8/14 in plasma and serum in patients with new-onset juvenile idiopathic arthritis in real-world setting in a single center PL Keskitalo, SM Kangas, S Sard, T Pokka, V Glumoff, P Kulmala, ... Pediatric Rheumatology 20 (1), 42, 2022 | 3 | 2022 |
| Homozygous TAF1C variants are associated with a novel childhood‐onset neurological phenotype O Knuutinen, A Pyle, M Suo‐Palosaari, J Duff, T Froukh, AE Lehesjoki, ... Clinical Genetics 98 (5), 493-498, 2020 | 3 | 2020 |
| ciRS-7 and miR-7 regulate ischemia-induced neuronal death via glutamatergic signaling F Scoyni, V Sitnikova, L Giudice, P Korhonen, DM Trevisan, AH de Sande, ... Cell Reports 43 (3), 2024 | 2 | 2024 |
| A novel pathogenic SLC12A5 missense variant in epilepsy of infancy with migrating focal seizures causes impaired KCC2 chloride extrusion V Järvelä, M Hamze, J Komulainen-Ebrahim, E Rahikkala, J Piispala, ... Frontiers in Molecular Neuroscience 17, 1372662, 2024 | 1 | 2024 |
| Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two: Genoa, Italy. 28 September – 01 October 2016 O Lomakina, E Alekseeva, S Valieva, T Bzarova, I Nikishina, E Zholobova, ... Pediatric Rheumatology 15, 105-201, 2017 | 1 | 2017 |
| Hyperkinetic Movement Disorder Caused by the Recurrent c.892C>T NACC1 Variant J Komulainen‐Ebrahim, SM Kangas, E López‐Martín, T Feyma, F Scaglia, ... Movement Disorders Clinical Practice 11 (6), 708-715, 2024 | | 2024 |
| FINCA disease mouse model exhibits altered behaviour and immune response AE Hiltunen, SM Kangas, A Gondane, H Koivisto, K Salokas, A Heikkinen, ... bioRxiv, 2024.06. 14.599017, 2024 | | 2024 |
| Infantile onset encephalomyopathy, retinopathy, optic atrophy, and mitochondrial DNA depletion associated with a novel pathogenic DHX16 variant MR Hautakangas, P Widgren, P Korpelainen, SM Kangas, T Komulainen, ... Clinical Genetics 104 (6), 686-693, 2023 | | 2023 |
